Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older
Clinical trial NCT03439657 · COMPLETED
Trial details
- NCT number
- NCT03439657
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-12
- Primary completion
- 2019-05-06
- Enrollment
- 913
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.